# Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis

> **NCT06865924** · NA · RECRUITING · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 80 (estimated)

## Conditions studied

- PSC

## Interventions

- **OTHER:** Use of assembloids as in vitro models to test new pharmacological approaches

## Key facts

- **NCT ID:** NCT06865924
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06865924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06865924, "Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06865924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*